• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai March 27

Wockhardt Ltd has received regulatory approvals in the United States to sell its diuretic Furosemide injection there. Furosemide injection is a widely used diuretic, or a drug that helps remove excess water from the body.

This is Wockhardt's second approval from the US Food and Drug Administration in a week, following the approval of painkiller Dextropropoxyphene/Acetaminophen tablets a few days ago.

Regulatory Process

Furosemide is also Wockhardt's fourth injection to receive approval from the US FDA, said the Wockhardt Chairman, Mr Habil Khorakiwala, in a statement issued on Tuesday. "Injectables are a key element of our US strategy. The regulatory process for approval of sterile injectables is complex and demanding, which limits the number of players in the market," he observed.

Wockhardt's US subsidiary, Wockhardt USA Inc, will shortly launch Furosemide injection in the US, the note said.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
NTC proposes special purpose vehicles for mill modernisaton

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line